CARDIOMETABOLIC HEALTH CONGRESS

Diabetes

Digital Education Hubs

Once thought to be purely an endocrine disorder, a more modern understanding of insulin resistance and glycemic regulation has revealed that prediabetes, type 1 and type 2 diabetes are hugely related to cardiometabolic disease and its many comorbidities. As the understanding of how diabetes is related to conditions like obesity and heart failure grows, more therapeutic targets are being identified, showing promise for many new treatments.

Expert Highlights and Perspectives

Recorded March 14, 2023
PODCAST ALSO AVAILABLE ON:
Episode 2:
How Much Can I Do in My Practice to Address Obesity?
Episode 3:
The Evolution of Obesity Treatment
Episode 1:
How to Initiate the Conversation About Obesity in Patients with Type 2 Diabetes  
Recorded October 27, 2022
In this 3-part podcast series, CMHC Co-chair Anne Peters, MD, Professor of Medicine at the University of Southern California, moderates discussions with Grazia Aleppo, MD, Professor of Medicine at Northwestern University, and Irl Hirsch, MD, Professor of Medicine at University of Washington, on the utility of CGM in patients with type 2 diabetes. They share important clinical pearls about the rationale and evidence for CGM in this setting, guidelines and patient selection, as well as how to implement CGM in patient care.
Hirsch_faculty
Peters
Aleppo_faculty
Recorded: October 27, 2022
Episode 3:
The Evolution of Obesity Treatment
Episode 1:
How to Initiate the Conversation About Obesity in Patients with Type 2 Diabetes  
Episode 2:
How Much Can I Do in My Practice to Address Obesity?
PODCAST ALSO AVAILABLE ON:
Obesity E1 1080x1080
In this podcast series, Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS, Associate Professor of Medicine and Pediatrics at Harvard Medical School interviews Scott Butsch, MD, MSc, FTOS Director of Obesity Medicine at the Cleveland Clinic, to discuss about the importance of addressing obesity in patients with type 2 diabetes mellitus (T2DM), as well as practical pearls to improve the treatment of obesity in these patients.  

PREDIABETES: SCREENING, DIAGNOSIS, AND MANAGEMENT

(Recorded April 2022)

Leigh Perreault, MD
Leigh Perreault,
MD

DUAL GLP-1/GIP AGONISTS: ARE THEY THE NEXT BIG THING IN DIABETES TREATMENT

(Recorded April 2022)

Athena Philis-Tsimikas,
MD

HOW CAN WE CONVERGE THE GLUCOCENTRIC AND CARDIO-RENAL RISK MANAGEMENT IN DIABETES PATIENTS

(Recorded April 2022)

Lawrence A. Leiter,
MD

THE EVOLUTION OF INSULIN: A 2022 UPDATE

(Recorded April 2022)

Grazia Aleppo,
MD

TECHNOLOGY IN DIABETES BEYOND CGM

(Recorded April 2022)

Steven J. Russell
MD, PhD

PANEL DISCUSSION ON DIABETES TECHNOLOGY: CGM AND BEYOND

(Recorded April 2022)

Steven J. Russell
MD, PhD
Anne L. Peters,
MD
Anne L. Peters,
MD
Leigh Perreault, MD
Leigh Perreault,
MD
Lawrence A. Leiter,
MD
Grazia Aleppo,
MD

PERSPECTIVES ON DIABETES MANAGEMENT

(Recorded April 2022)

News Digest

Key Updates in the 2025 American Diabetes Association (ADA) Diabetes Guidelines 

Explore the 2025 ADA Standards of Care in Diabetes to improve care delivery!

FDA Approvals (July 2024 – January 2025): Advancements in Cardiorenal and Cardiometabolic Health 

Get the latest FDA-approved drugs and devices for cardiometabolic and cardiorenal conditions and risk factors. Explore now!

The Digital Revolution in Diabetes Care: Turning Clinical Challenges into Patient Success

Read on for the current challenges and actionable steps to integrate CGM and other digital tools into diabetes care.

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

What happened at the 19th Annual CMHC? Get daily highlights, event photos, and read a poignant quote from keynote Dr. Peter Libby.

FDA Approves First Year-Long Continuous Glucose Monitoring Sensor for Diabetes

Discover the impact of this breaking FDA approval of the first year-long Continuous Glucose Monitoring sensor—READ NOW!

CMHC Presents at ADA 2024: Key Findings and Insights

Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress, Informa Connect, presented CME webcast study at ADA 2024.

The New Era of Continuous Glucose Monitoring (CGM) Expanding Access and Improving Outcomes

Explore advancements in OTC CGM systems. Plus, uncover the broader implications of these cutting-edge devices!

Cardiometabolic Health Congress Hosts the 2024 Women’s Masterclass in California to Advance Cardio-renal-metabolic Care for Women  

5 Keys to Patient Education on GLP-1 RAs for Weight Loss

article

Atherosclerosis/Thrombosis

article

Atherosclerosis/Thrombosis

article

Atherosclerosis/Thrombosis

article

Care Delivery Implementation

This clinical brief was developed from a session at the 17th Annual Cardiometabolic Health Congress (CMHC) presented by Irl B Hirsch, MD from the University

article

Cardiometabolic Disease

The experts behind Cardiometabolic Health Congress have identified 10 stories in cardiorenal medicine to watch in 2023.

article

Diabetes

Sanofi was the last of three pharmaceutical goliaths to announce they’d make good on their long-spoken promise to lower the price of their insulin.

Drug Pipeline

Drug Pipeline Coming Soon

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

#C1E5E9

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Resources

American Diabetes Association – 2022 Standards of Medical Care in Diabetes
Diabetes Technology – Standards of Medical Care in Diabetes – 2022
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes – 2022
AACE: 2021 Advances Diabetes Technology Guideline
AHA Scientific Statement: Comprehensive Management of Cardiovascular Risk Factors For Adults with Type 2 Diabetes
Why Should We Use CGM in Patients With Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
CGM Metrics and Interpretation
Features of Available CGM Systems
Personal & Professional CGM Billing
Interfering Substances in CGM Systems